Articles from BIOCORP

Novo Nordisk Enters Into Exclusive Negotiations to Acquire a Controlling Stake in BICORP, to Be Followed by a Tender Offer on All Remaining Shares.

Regulatory News:

By BIOCORP · Via Business Wire · June 5, 2023

BIOCORP Obtains 510(k) FDA Clearance for Mallya®

Regulatory News:

By BIOCORP · Via Business Wire · December 7, 2022

BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya® Smart Sensor

Regulatory News:

By BIOCORP · Via Business Wire · October 26, 2022

BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs

Regulatory News:

By BIOCORP · Via Business Wire · October 18, 2022

BIOCORP and Merck KGaA, Darmstadt, Germany, Sign a New Partnership for Smart Drug Delivery

Regulatory News:

By BIOCORP · Via Business Wire · October 10, 2022

BIOCORP announces the CE marking of SoloSmart®, an accessory medical device for SANOFI Solostar® pens at the occasion of EASD

Regulatory News:

By BIOCORP · Via Business Wire · September 19, 2022

BIOCORP Signs New Partnership Around InspairTM With H&T Presspart

Regulatory News:

By BIOCORP · Via Business Wire · December 16, 2021

BIOCORP and NOVO NORDISK Sign Global Partnership Within Diabetes on Digital Health

Regulatory News:

By BIOCORP · Via Business Wire · September 27, 2021

BIOCORP and MERCK Sign a Partnership in the Field of Human Growth Hormone (HGH)

Regulatory News:

By BIOCORP · Via Business Wire · September 16, 2021

BIOCORP and ROCHE DIABETES CARE FRANCE Launch Mallya, an Innovative Medical Device to Better the Daily Life of Patients With Diabetes

Regulatory News:

By BIOCORP · Via Business Wire · April 13, 2021